Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?

Spinello A, Vecile E, Abbate A, Dobrina A, Magistrato A.

J Chem Inf Model. 2019 Jan 28;59(1):351-359. doi: 10.1021/acs.jcim.8b00565. Epub 2019 Jan 10.

2.

Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes.

Vecile E, Dobrina A, Salloum FN, Van Tassell BW, Falcione A, Gustini E, Secchiero S, Crovella S, Sinagra G, Finato N, Nicklin MJ, Abbate A.

PLoS One. 2013;8(1):e53265. doi: 10.1371/journal.pone.0053265. Epub 2013 Jan 8.

3.

Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse.

Abbate A, Salloum FN, Van Tassell BW, Vecile E, Toldo S, Seropian I, Mezzaroma E, Dobrina A.

PLoS One. 2011;6(11):e27923. doi: 10.1371/journal.pone.0027923. Epub 2011 Nov 28.

4.

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A.

Circulation. 2008 May 20;117(20):2670-83. doi: 10.1161/CIRCULATIONAHA.107.740233. Epub 2008 May 12.

PMID:
18474815
5.

Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X.

Lanza GA, Sestito A, Cammarota G, Grillo RL, Vecile E, Cianci R, Speziale D, Dobrina A, Maseri A, Crea F.

Am J Cardiol. 2004 Jul 1;94(1):40-4.

PMID:
15219506
6.

Soluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy?

Abbate A, Biondi-Zoccai GG, Vecile E, Dobrina A.

Eur J Clin Invest. 2003 Nov;33(11):1020; author reply 1021. No abstract available.

PMID:
14636309
7.

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke.

Seripa D, Dobrina A, Margaglione M, Matera MG, Gravina C, Vecile E, Fazio VM.

Cerebrovasc Dis. 2003;15(4):276-81.

PMID:
12686792
8.

Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells.

Mancardi S, Vecile E, Dusetti N, Calvo E, Stanta G, Burrone OR, Dobrina A.

Immunology. 2003 Apr;108(4):523-30.

9.

Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction.

Abbate A, Vecile E, Fiotti N, Giansante C, Guarnieri G, Di Sciascio G, Dobrina A.

Eur J Heart Fail. 2003 Jan;5(1):23-5. No abstract available.

10.

Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo.

Dobrina A, Pausa M, Fischetti F, Bulla R, Vecile E, Ferrero E, Mantovani A, Tedesco F.

Blood. 2002 Jan 1;99(1):185-92.

PMID:
11756170
11.

Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors.

Lorenzon P, Vecile E, Nardon E, Ferrero E, Harlan JM, Tedesco F, Dobrina A.

J Cell Biol. 1998 Sep 7;142(5):1381-91.

12.

Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes.

Cinco M, Vecile E, Murgia R, Dobrina P, Dobrina A.

FEMS Microbiol Lett. 1996 May 1;138(2-3):211-4.

PMID:
9026448
13.

Supplemental Content

Loading ...
Support Center